《大行報告》瑞信下調潤地(01109.HK)目標價至45.36元 評級「跑贏大市」
瑞信發表研究報告,指華潤置地(01109.HK)去年核心純利按年升1.5%至270億元人民幣,符該行及市場預期。全年派息按年升1.5%至140分人民幣,分派比率維持37%,意味股息率4.5%。淨負債率升至35%。
報告引述管理層指引今年合約銷售料穩定。投資物業方面,指引未來三年每年新開10至15個商場,該行料將長遠支持經常性收益穩定增長。
瑞信指喜好潤地強勁資產負債表,補充具質素土儲,以及有具韌性租金收入,支持更平衡增長,降今明兩年盈測各10%,目標價由47.33元降至45.36元, 評級「跑贏大市」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.